These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 19240977)

  • 1. Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4.
    Huang WJ; Zhang HY; Harrison TJ; Lan HY; Huang GY; Wang YC
    Arch Virol; 2009; 154(3):481-8. PubMed ID: 19240977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes.
    Arankalle VA; Lole KS; Deshmukh TM; Srivastava S; Shaligram US
    Vaccine; 2009 Feb; 27(7):1032-9. PubMed ID: 19095027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-protection of hepatitis E virus genotypes 1 and 4 in rhesus macaques.
    Huang W; Zhang H; Harrison TJ; Lang S; Huang G; Wang Y
    J Med Virol; 2008 May; 80(5):824-32. PubMed ID: 18360896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs.
    Sanford BJ; Opriessnig T; Kenney SP; Dryman BA; Córdoba L; Meng XJ
    Vaccine; 2012 Sep; 30(44):6249-55. PubMed ID: 22906724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and efficacy of a bacterially expressed HEV ORF3 peptide, assessed by experimental infection of primates.
    Ma H; Song X; Harrison TJ; Li R; Huang G; Zhang H; Kong W; Wang Y
    Arch Virol; 2009; 154(10):1641-8. PubMed ID: 19763777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination of rhesus monkeys with recombinant antigen fragments and protection from hepatitis E virus infection].
    Ma YB; Xie TH; Zhang GM; Li CH; Dai XJ; Dai CB; Sun MS; Lu J; Bi SL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):592-5. PubMed ID: 12905686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
    Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
    Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific memory B cell response and participation of CD4
    Kulkarni SP; Thanapati S; Arankalle VA; Tripathy AS
    Vaccine; 2016 Nov; 34(48):5895-5902. PubMed ID: 27997340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells.
    Zhang M; Emerson SU; Nguyen H; Engle RE; Govindarajan S; Gerin JL; Purcell RH
    Vaccine; 2001 Dec; 20(5-6):853-7. PubMed ID: 11738749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The immuno-protect study of a hepatitis E virus ORF2 peptide expressed in E. coli].
    Ge S; Zhang J; Huang G; Pang S; Zhou K; Xia N
    Wei Sheng Wu Xue Bao; 2003 Feb; 43(1):35-42. PubMed ID: 16276869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity difference between two hepatitis E vaccines derived from genotype 1 and 4.
    Wen J; Behloul N; Dai X; Dong C; Liang J; Zhang M; Shi C; Meng J
    Antiviral Res; 2016 Apr; 128():36-42. PubMed ID: 26850829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of chickens against avian hepatitis E virus (avian HEV) infection by immunization with recombinant avian HEV capsid protein.
    Guo H; Zhou EM; Sun ZF; Meng XJ
    Vaccine; 2007 Apr; 25(15):2892-9. PubMed ID: 17074425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
    Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
    Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV).
    Purdy MA; McCaustland KA; Krawczynski K; Spelbring J; Reyes GR; Bradley DW
    J Med Virol; 1993 Sep; 41(1):90-4. PubMed ID: 8228944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary evidence that a hepatitis E virus (HEV) ORF2 recombinant protein protects cynomolgus macaques against challenge with wild-type HEV].
    Bi S; Lu J; Jiang L; Huang G; Pan H; Jiang Y; Zhang M; Shen X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Mar; 16(1):31-2. PubMed ID: 11986741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge.
    Tsarev SA; Tsareva TS; Emerson SU; Govindarajan S; Shapiro M; Gerin JL; Purcell RH
    Vaccine; 1997 Dec; 15(17-18):1834-8. PubMed ID: 9413090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of recombinant Chinese avian hepatitis E virus (CaHEV) ORF2 and ORF3 proteins for protection of chickens against CaHEV infection.
    Syed SF; Sun Y; Du T; Chen Y; Liu B; Wang X; Li H; Nan Y; Zhou EM; Zhao Q
    Vaccine; 2017 Jun; 35(27):3482-3489. PubMed ID: 28528763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of hepatitis E virus infection at a rhesus monkey farm in China.
    Yang F; Duan S; Guo Y; Li Y; Yoshizaki S; Takeda N; Wakita T; Muramatsu M; Zhao Y; He Z; Li TC
    Vet Microbiol; 2019 Mar; 230():244-248. PubMed ID: 30827396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques.
    Zhang M; Emerson SU; Nguyen H; Engle R; Govindarajan S; Blackwelder WC; Gerin J; Purcell RH
    Vaccine; 2002 Sep; 20(27-28):3285-91. PubMed ID: 12213398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection.
    Kamili S; Spelbring J; Carson D; Krawczynski K
    J Infect Dis; 2004 Jan; 189(2):258-64. PubMed ID: 14722891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.